If you have questions, please call us for more information about clinical trials or use our online form.

Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.  

Displaying 161 - 170 of 281

A Phase 2, Multicenter, Randomized, Open-Label Trial of GEN1046 as Monotherapy and in Combination with Pembrolizumab in Subjects with Relapsed/Refractory Metastatic Non-Small Cell Lung Cancer After Treatment with Standard of Care Therapy with an Immu

This trial is being run to find out how well the trial drug GEN1046 acts against NSCLC and if it is safe both as single treatment and in combination with Pembrolizumab to treat your NSCLC.
Protocol No
GENMAB-GCT1046-04